J S Huston1, A J George, G P Adams
1Creative BioMolecules, Inc., Department of Immunology, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Engineered single-chain variable fragment (sFv) proteins show promise for radioimmunotargeting. Optimizing administration routes and radiolabeling strategies enhances tumor targeting specificity for improved cancer imaging and therapy.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: